Laurus Labs Limited (LAURUSLABS.NS) stock analysis

In our weekly check, Laurus Labs Limited is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 20 pass, warnings: 3, red flags: 2.

About Laurus Labs Limited

Laurus Labs Limited is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in India, listed on NSE as LAURUSLABS.NS.

What our checks show for LAURUSLABS.NS

Red flags

• The gross margin fell by 7.5 points, to 46.9%: costs are rising faster than prices.
• Return on capital (ROCE) is zero or negative: the business does not earn on the money put into it.

Warning signs

• The net margin fell by 1.7 points over 5 years, to 15%: the company keeps less of each sale as profit.
• The stock has fallen as much as 59% from a peak. Would you have held through that?
• Recovering from its deepest fall took about 2.2 years.

Strengths

• Debt is low: 0x equity.
• Operating profit covers interest 9.6 times over.
• Operating cash flow is 1.33x net profit: the profit arrives as real cash.
• Analysts expect earnings per share to grow about 26.8% a year over the next years.
• Analysts expect revenue to grow about 18.6% a year over the next years.
• Analysts expect the net margin to improve by 3.6 points from today's 15%.

Next earnings report: 2026-10-29

Similar companies

LUPIN.NS · 4523.T · TORNTPHARM.NS · 6446.TW · DIVISLAB.NS · 4507.T

Questions

What grade does Laurus Labs Limited (LAURUSLABS.NS) have?

In our weekly check, Laurus Labs Limited is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 20 pass, warnings: 3, red flags: 2. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of LAURUSLABS.NS stock?

This week's biggest flags for Laurus Labs Limited: Gross margin falling, Low return on capital, Margins falling. In total 5 of 25 checks show a warning or a red flag.

What does Laurus Labs Limited do?

Laurus Labs Limited is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in India, listed on NSE as LAURUSLABS.NS.

When does Laurus Labs Limited report earnings next?

The next earnings report is expected on 2026-10-29. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-24

Open the full analysis